Chris Hemsworth co-founds KINSYN, a wellness platform that uses AI on medical and wearable data
Actor Chris Hemsworth has co-founded KINSYN, a personalised wellness platform that launched in the US on 12 November, according to a press release.
KINSYN pulls together medical records from participating US healthcare systems with biomarker tests, wearable data and lifestyle information. Proprietary AI helps its physicians turn that data into individual recommendations, which can include prescription therapies, supplements and further lab tests depending on a member's needs and medical eligibility. Medical care and prescriptions are provided through affiliated medical practices run by licensed professionals, and an advisory board of physicians and researchers covers areas such as metabolic health, genomics, women's health and longevity.
"The more I've learned in this space, the more I've realized that there isn't one answer for everyone," Hemsworth said. The release does not give membership prices, the participating health systems or details of the AI models used.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 12 Kno2 connects Microsoft Azure healthcare customers to its national clinical data network Nov 12 Penguin Ai survey: 62% of patients facing prior authorization delays gave up on care Nov 12 Orakl Oncology Raises $34 Million to Predict Cancer Drug Response With AI Nov 12 Araceli Biosciences Adds Investor to $4.5 Million Round Nov 12 DarioHealth Q3 Revenue Rises 6% to $5.3 MillionLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Alethios Adds Decentralized Health Research Data Suite
Helfie AI and Health Innovation South West to Test Smartphone Hypertension Screening
OPFIT launches OptimalFit AI fitness platform
Kipu Health Launches AI Agent for Behavioral Health Reviews
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
Daily AI Brief: the AI news that matters, in your inbox.